These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30195650)

  • 1. Mechanistic study on hydrodynamics in the mini-scale biphasic dissolution model and its influence on in vitro dissolution and partitioning.
    Locher K; Borghardt JM; Wachtel H; Schaefer KJ; Wagner KG
    Eur J Pharm Sci; 2018 Nov; 124():328-338. PubMed ID: 30195650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of a mini-scale biphasic dissolution model: Impact of model parameters on partitioning of dissolved API and modelling of in vivo-relevant kinetics.
    Locher K; Borghardt JM; Frank KJ; Kloft C; Wagner KG
    Eur J Pharm Biopharm; 2016 Aug; 105():166-75. PubMed ID: 27297570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo predictive mini-scale dissolution for weak bases: Advantages of pH-shift in combination with an absorptive compartment.
    Frank KJ; Locher K; Zecevic DE; Fleth J; Wagner KG
    Eur J Pharm Sci; 2014 Sep; 61():32-9. PubMed ID: 24413061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a biphasic in vitro dissolution test for estimating the bioavailability of carbamazepine polymorphic forms.
    Deng J; Staufenbiel S; Bodmeier R
    Eur J Pharm Sci; 2017 Jul; 105():64-70. PubMed ID: 28487146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test.
    Heigoldt U; Sommer F; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2010 Sep; 76(1):105-11. PubMed ID: 20472059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Partition Rate of Ibuprofen Across the Water-Octanol Interface and the Influence of Common Pharmaceutical Excipients.
    Xu H; Wang W; Shi Y; Gao P
    J Pharm Sci; 2019 Jan; 108(1):525-537. PubMed ID: 30471290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrodynamic Effects on Drug Dissolution and Deaggregation in the Small Intestine-A Study with Felodipine as a Model Drug.
    Lindfors L; Jonsson M; Weibull E; Brasseur JG; Abrahamsson B
    J Pharm Sci; 2015 Sep; 104(9):2969-76. PubMed ID: 25980801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Models for USP2 Dissolution Apparatus, Including Fluid Hydrodynamics and Sedimentation.
    Pepin X; Goetschy M; Abrahmsén-Alami S
    J Pharm Sci; 2022 Jan; 111(1):185-196. PubMed ID: 34666045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of a biphasic test for characterization of in vitro drug release of immediate release formulations of celecoxib and its relevance to in vivo absorption.
    Shi Y; Gao P; Gong Y; Ping H
    Mol Pharm; 2010 Oct; 7(5):1458-65. PubMed ID: 20704265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rational Design of a Biphasic DissolutionSetup-Modelling of Biorelevant Kinetics for a Ritonavir Hot-Melt Extruded Amorphous Solid Dispersion.
    Denninger A; Westedt U; Rosenberg J; Wagner KG
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32155962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of supersaturation level for oral absorption of BCS class IIb drugs, dipyridamole and ketoconazole, using in vivo predictive dissolution system: Gastrointestinal Simulator (GIS).
    Tsume Y; Matsui K; Searls AL; Takeuchi S; Amidon GE; Sun D; Amidon GL
    Eur J Pharm Sci; 2017 May; 102():126-139. PubMed ID: 28263914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a discriminative biphasic in vitro dissolution test and correlation with in vivo pharmacokinetic studies for differently formulated racecadotril granules.
    Deng J; Staufenbiel S; Hao S; Wang B; Dashevskiy A; Bodmeier R
    J Control Release; 2017 Jun; 255():202-209. PubMed ID: 28450206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation.
    McCarthy CA; Faisal W; O'Shea JP; Murphy C; Ahern RJ; Ryan KB; Griffin BT; Crean AM
    J Control Release; 2017 Mar; 250():86-95. PubMed ID: 28132935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Hydrodynamics in a Miniaturized Dissolution Apparatus.
    Johansson KE; Plum J; Mosleh M; Madsen CM; Rades T; Müllertz A
    J Pharm Sci; 2018 Apr; 107(4):1095-1103. PubMed ID: 29233728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of Gastrointestinal Simulator, an in Vivo Predictive Dissolution Methodology, Coupled with Computational Approach To Forecast Oral Absorption of Dipyridamole.
    Matsui K; Tsume Y; Takeuchi S; Searls A; Amidon GL
    Mol Pharm; 2017 Apr; 14(4):1181-1189. PubMed ID: 28231003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopharmaceutic IVIVE-Mechanistic Modeling of Single- and Two-Phase In Vitro Experiments to Obtain Drug-Specific Parameters for Incorporation Into PBPK Models.
    Pathak SM; Schaefer KJ; Jamei M; Turner DB
    J Pharm Sci; 2019 Apr; 108(4):1604-1618. PubMed ID: 30476508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a digital twin of a tablet that mimics a real solid dosage form: Differences in the dissolution profile in conventional mini-USP II and a biorelevant colon model.
    Schütt M; Stamatopoulos K; Batchelor HK; Simmons MJH; Alexiadis A
    Eur J Pharm Sci; 2022 Dec; 179():106310. PubMed ID: 36265815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.